Avantor (NYSE:AVTR) Rating Lowered to “Neutral” at Bank of America

Avantor (NYSE:AVTR) was downgraded by research analysts at Bank of America from a “buy” rating to a “neutral” rating in a research note issued to investors on Monday, Marketbeat.com reports. They currently have a $13.00 price target on the stock. Bank of America‘s price objective indicates a potential upside of 16.23% from the company’s previous close.

Other analysts also recently issued reports about the company. Raymond James Financial downgraded Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $12.00 price target (down previously from $14.00) on shares of Avantor in a report on Thursday, October 30th. Barclays restated an “equal weight” rating and set a $12.00 price objective (down from $15.00) on shares of Avantor in a research note on Thursday, October 30th. Evercore ISI cut their price objective on shares of Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Thursday, October 30th. Finally, Robert W. Baird increased their target price on shares of Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat, Avantor presently has a consensus rating of “Hold” and a consensus target price of $14.32.

Avantor Stock Performance

AVTR opened at $11.19 on Monday. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The company’s fifty day moving average price is $12.35 and its two-hundred day moving average price is $12.82. Avantor has a 1-year low of $10.62 and a 1-year high of $23.32. The company has a market cap of $7.63 billion, a price-to-earnings ratio of -86.04, a PEG ratio of 3.88 and a beta of 0.93.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the prior year, the business earned $0.26 earnings per share. The firm’s quarterly revenue was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, analysts expect that Avantor will post 1.06 EPS for the current fiscal year.

Insider Transactions at Avantor

In related news, Director Gregory L. Summe bought 100,000 shares of Avantor stock in a transaction dated Thursday, October 30th. The stock was purchased at an average cost of $11.25 per share, with a total value of $1,125,000.00. Following the transaction, the director directly owned 300,000 shares of the company’s stock, valued at approximately $3,375,000. The trade was a 50.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Sanjeev K. Mehra purchased 350,000 shares of the stock in a transaction that occurred on Friday, December 5th. The stock was bought at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the acquisition, the director directly owned 350,000 shares in the company, valued at $3,881,500. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Avantor

Hedge funds and other institutional investors have recently bought and sold shares of the business. Rise Advisors LLC bought a new position in shares of Avantor in the first quarter worth $25,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Avantor by 288.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after purchasing an additional 1,263 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC purchased a new position in Avantor during the 2nd quarter valued at about $32,000. Finally, FNY Investment Advisers LLC bought a new stake in shares of Avantor during the second quarter valued at about $36,000. Institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.